Gubra ASFRA:PI3 +1.71%73 PS Ratio is 2.05 as of Jul. 01, 2026, which is 91% below its 10-year median of 21.90. GuruFocus rates FRA:PI3 with a GF Score™ of 73/100 and a GF Value™ of €389.49 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 934 Biotechnology companies, Gubra AS ranks better than 84.9% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Gubra AS's share price is €44.08.
Gubra AS's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €21.47. Hence, Gubra AS's PS Ratio for today is 2.05.
Good Sign:
Gubra AS stock PS Ratio (=2.01) is close to 5-year low of 1.99.
The historical rank and industry rank for Gubra AS's PS Ratio or its related term are showing as below:
FRA:PI3'
s PS Ratio Range Over the Past 10 Years
Min: 1.99 Med: 21.9 Max: 51.8
Current: 2.04
During the past 7 years, Gubra AS's highest PS Ratio was 51.80. The lowest was 1.99. And the median was 21.90.
FRA:PI3's PS Ratio is ranked better than 84.9% of 934
companies
in the Biotechnology industry
Industry Median: 9.515
vs FRA:PI3: 2.04
During the past 12 months, the average Revenue per Share Growth Rate of Gubra AS was 882.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 135.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 48.50% per year.
During the past 7 years, Gubra AS's highest 3-Year average Revenue per Share Growth Rate was 135.90% per year. The lowest was 1.40% per year. And the median was 8.60% per year.
Back to Basics: PS Ratio
Gubra AS (FRA:PI3) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gubra AS PS Ratio Related Terms
Gubra AS PS Ratio Historical Data
* Premium members only.
The historical data trend for Gubra AS's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Gubra AS's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gubra AS PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gubra AS's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gubra AS's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gubra AS's Share Price of today is €44.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gubra AS's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €21.47.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gubra AS (FRA:PI3) has a PS Ratio of 2.05 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gubra AS and its competitors. This is 91% below median its historical median of 21.90. Over the past decade, Gubra AS's PS Ratio has ranged from 1.99 to 51.80. According to the industry distribution chart, Gubra AS ranks #141 out of 934 companies in the Biotechnology industry, placing it in the top 15.1%.
Is Gubra AS's PS Ratio too high?
Gubra AS's current PS Ratio of 2.05 is 91% below median its 10-year median of 21.90. Over the past 10 years, this metric has ranged from a low of 1.99 to a high of 51.80. The Biotechnology industry median PS Ratio is 9.52. Gubra AS's value of 2.05 is 78.5% below this industry median. Based on the distribution chart, Gubra AS ranks #141 out of 934 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gubra AS has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #141 out of 934 companies for PS Ratio. This places Gubra AS in the top 15% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.52. Gubra AS's value of 2.05 is 78.5% below this benchmark. Historically, Gubra AS's own PS Ratio has ranged from 1.99 to 51.80 over the past decade. While the company's 10-year median is 21.90 vs. the industry median of 9.52, Gubra AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.52, based on 934 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gubra AS's current PS Ratio of 2.05 is 78.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gubra AS and its competitors. For the Biotechnology industry, the median PS Ratio is 9.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gubra AS's current PS Ratio is 2.05, which is 91% below median its own 10-year median of 21.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €389.49, compared to a current price of €44.08 — trading 88.7% below its estimated fair value. The current PS Ratio is 2.05, which is 91% below median its 10-year median of 21.90 and 78.5% below the Biotechnology industry median of 9.52. Gubra AS's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current PS Ratio is 2.05 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gubra AS (FRA:PI3) Overvalued in 2026?
Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued.
The current stock price of €44.08 is trading 88.7% below its estimated GF Value™ of €389.49.
GuruFocus considers Gubra AS to be Possible Value Trap.
Key valuation signals for FRA:PI3:
PS Ratio: 2.05 (91% below median its 10-year median of 21.90)
GF Value™: €389.49 vs. price of €44.08 (88.7% below fair value)
Industry Position: 78.5% below the Biotechnology median (#141 of 934)
No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score
Get the complete analysis for FRA:PI3
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PI3 has been successfully added to your 
